Cancer research
Hematopoietic stem progenitor cells (HSPCs) undergo a complex process of engraftment and homing in bone marrow during hematopoietic transplantation. Recent research has shed light on the role of the complement system in modulating HSPCs' responsiveness to stromal-derived factor-1 (SDF-1). However, the involvement of the C3a-C3aR axis in this process
Cancer
Recent research published in the journal Molecular Cancer Therapeutics has shed light on the potential of histone methylation inhibitors in cancer therapy. A study conducted by researchers at the University of California found that 3-deazaneplanocin A (DZNep), a compound that selectively inhibits histone methylation, can reactivate silenced genes in cancer
Cancer
Scientists in Changsha, People's Republic of China, have made a significant discovery in the field of cancer research. Transforming growth factor-beta (TGF-beta) has been found to play a crucial role in the invasion and metastasis of gastric cancer cells. The study, led by H. Fu and colleagues, found
Cancer
Scientists in Chongqing, People's Republic of China, have made a significant discovery in the field of cancer research. They have identified a novel multi-drug resistance gene, HA117, which significantly increases the drug resistance of chronic myelogenous leukemia cell line K562. The researchers found that expression of the HA117
Cancer
A new report from researchers at Nanjing University in China has made significant findings in the development of a novel cancer treatment. The study used the probiotic Bifidobacterium longum as a delivery system for the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and endostatin, which when combined with low-dose chemotherapeutic drugs,
Cancer
Recent research from Wake Forest University's Medical Department has provided significant insights into the molecular events underlying cell death triggered by the cancer chemotherapeutic drug cisplatin. The study discovered that mismatch repair (MMR) proteins participate in cytotoxicity induced by cisplatin, a key finding that can improve our understanding
Cancer
A nonviral gene delivery system using a composite of piggyBac (PB) transposon and polyethylenimine (PEI) was developed to support stable genomic integration and persistent gene expression in vivo. In a study published in BMC Cancer, researchers from Fudan University successfully applied this system to treat ovarian cancer in mice. The
Cancer
Researchers in Caen, France, have found that the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) has limited effectiveness in treating malignant glioma, a type of brain cancer. The study, published in Clinical Cancer Research, used a panel of six human malignant gliomas with different molecular alterations
Cancer
Scientists in Luxembourg have made a significant breakthrough in cancer research by investigating the potential of naturally occurring organic sulfur compounds (OSCs) in treating leukemia. Their study, published in Apoptosis, has identified a compound, diallyltetrasulfide (Al2S4), which has shown promise in inducing apoptosis in cancer cells. The researchers found that
Cancer
Scientists at Kyungpook National University have discovered that a specific polymorphism in the TP53 codon 72 gene is associated with a lower response rate to chemotherapy and poor prognosis in patients with advanced gastric cancer. The study, published in Cancer Chemotherapy and Pharmacology, analyzed the genomic DNA of 57 patients
Cancer
Research findings suggest that mutations in the BRAF, RAS, and EGFR genes may play a significant role in the development of human adrenocortical carcinomas. According to a new report published in the journal Endocrine-related Cancer, the serine/threonine kinase B-Raf and the epidermal growth factor receptor (EGFR) are key players
Cancer
Recent years have seen a significant increase in the development of protein kinase inhibitors as a therapeutic approach for various diseases, including cancer. However, the challenge of modulating protein kinase activities safely and effectively for the treatment of chronic diseases remains unresolved. Researchers have identified several protein kinases, including p38
